Skip to content

Effect of hypertension on oral implant prognosis and surgical safety in elderly patients: A prospective cohort study

Effect of hypertension on oral implant prognosis and surgical safety in elderly patients: A prospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108278
Enrollment
Unknown
Registered
2025-08-27
Start date
2025-05-28
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth loss

Interventions

Control group:None
Exposure group:None

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for the exposure group: (1) Age 60~90 years old (including upper and lower limits); (2) Implant denture restoration is required, and this implant is a local anesthetic surgery; (3) Diagnosed with hypertension, and the standard treatment time >=3 months, the average blood pressure in the two clinics was < 160/100mmHg; (4) Volunteer to participate in the study, cooperate with the examination and sign the informed consent form; 2. Inclusion criteria for the control group: (1) Age 60~90 years old (including upper and lower limits); (2) Implant denture restoration is required, and this implant is a local anesthetic surgery; (3) no hypertension; (4) Volunteer to participate in the study, cooperate with the examination and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Obvious oral abscesses, precancerous lesions, fungal infections and wisdom tooth pericoronitis in the whole mouth; 2. Blood pressure on the day of surgery >=180/110mmHg or <90/60mmHg; 3. Patients with myocardial infarction or heart failure within 6 months; 4. Patients with cerebrovascular accident, syncope or unstable angina within 3 months; 5. Coagulation dysfunction, thrombocytopenia, hemophilia or significant anemia; 6. Patients with diabetes and renal hypertension; 7. History of intravenous bisphosphonate use; 8. Those who use immunosuppressants; 9. Malignant tumors have not been treated standardly, or less than 5 years after standardized treatment; 10. Diagnosed with acquired immunodeficiency syndrome, syphilis and hepatitis B, without standardized treatment and control; 11. Patients with severe cognitive impairment (dementia), schizophrenia, and severe depression.

Design outcomes

Primary

MeasureTime frame
The incidence of peri-implantitis one year after the completion of implant restoration;

Secondary

MeasureTime frame
Local safety;The incidence of complications of the implant within one year after implant restoration;Subjective evaluation of patients within one year after implant restoration;Systemic safety during the perioperative period;The score results of the cognitive scale one year after implant restoration;

Countries

China

Contacts

Public ContactDuohong Zou

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

zouduohongyy@163.com+86 13601645549

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026